Bristol Myers Squibb Builds a Second NVIDIA-Based AI Supercomputer for Drug Discovery

Bristol Myers Squibb is deploying a second NVIDIA DGX SuperPOD, built on NVIDIA's upcoming Vera Rubin chips, for life-science AI work.